Evidence map›Paper›PMID 28894120›Full record

ArticleScientific reports2017

Blood triglyceride levels are associated with DNA methylation at the serine metabolism gene PHGDH.

Vinh Truong, Siying Huang, Jessica Dennis, Mathieu Lemire, Nora Zwingerman, Dylan Aïssi, Irfahan Kassam, Claire Perret, Philip Wells, Pierre-Emmanuel Morange and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.Cellular oncology (Dordrecht, Netherlands) · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Vinh TruongDivision of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Siying HuangDivision of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Jessica DennisDivision of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Mathieu LemireOntario Institute for Cancer Research, Toronto, Canada.
Nora ZwingermanDivision of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Dylan AïssiSorbonne Universités, UPMC Univ. Paris 06, INSERM, UMR_S 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases, Paris, France.
Irfahan KassamDivision of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Claire PerretSorbonne Universités, UPMC Univ. Paris 06, INSERM, UMR_S 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases, Paris, France.
Philip WellsDepartment of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Pierre-Emmanuel MorangeINSERM, UMR_S 1062, Nutrition Obesity and Risk of Thrombosis, Marseille, France.
Michael WilsonGenetics and Genome Biology Program, SickKids Research Institute, Toronto, Canada.ORCID 0000-0002-4015-3066
David-Alexandre TrégouëtSorbonne Universités, UPMC Univ. Paris 06, INSERM, UMR_S 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases, Paris, France.
France GagnonDivision of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. france.gagnon@utoronto.ca.
University of Toronto · CAInserm · FROntario Institute for Cancer Research · CASickKids Foundation · CAUniversity of Ottawa · CA

Funding

CIHR
6 · The paper itself

Abstract

Efficient interventions to reduce blood triglycerides are few; newer and more tolerable intervention targets are needed. Understanding the molecular mechanisms underlying blood triglyceride levels variation is key to identifying new therapies. To explore the role of epigenetic mechanisms on triglyceride levels, a blood methylome scan was conducted in 199 individuals from 5 French-Canadian families ascertained on venous thromboembolism, and findings were replicated in 324 French unrelated patients with venous thromboembolism. Genetic context and functional relevance were investigated. Two DNA methylation sites associated with triglyceride levels were identified. The first one, located in the ABCG1 gene, was recently reported, whereas the second one, located in the promoter of the PHGDH gene, is novel. The PHGDH methylation site, cg14476101, was found to be associated with variation in triglyceride levels in a threshold manner: cg14476101 was inversely associated with triglyceride levels only when triglyceride levels were above 1.12 mmol/L (discovery P-value = 8.4 × 10

Indexed as

DNA MethylationPromoter Regions, GeneticAdultATP Binding Cassette Transporter, Subfamily G, Member 1CanadaEpigenesis, GeneticFamily HealthFemaleHumansMaleMiddle AgedPhosphoglycerate DehydrogenaseTriglyceridesYoung AdultABCG1 protein, humanATP Binding Cassette Transporter, Subfamily G, Member 1Phosphoglycerate DehydrogenaseTriglycerides

Identifiers

PMID28894120
PMCPMC5593822
OpenAlexW2751811196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.